K200676

Substantially Equivalent

ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA

Applicant: Zirkonzahn Srl
Product code: EBG
Advisory panel: Dental
Date received: 2020-03-16
Decision date: 2020-07-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Gais, IT

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.